Combined genomic and phenotype screening reveals secretory factor SPINK1 as an invasion and survival factor associated with patient prognosis in breast cancer
about
Global gene expression profiling reveals SPINK1 as a potential hepatocellular carcinoma markerClinical evaluation of a multiple-gene sequencing panel for hereditary cancer risk assessmentSystems consequences of amplicon formation in human breast cancerJMJD6 promotes colon carcinogenesis through negative regulation of p53 by hydroxylation.SPINK1 Promoter Variants Are Associated with Prostate Cancer Predisposing Alterations in Benign Prostatic Hyperplasia Patients.Gene expression and pathway analysis of human hepatocellular carcinoma cells treated with cadmiumJMJD6 is a driver of cellular proliferation and motility and a marker of poor prognosis in breast cancer.SPINK1 promotes colorectal cancer progression by downregulating Metallothioneins expression.Serine protease inhibitor Kazal type 1 (SPINK1) drives proliferation and anoikis resistance in a subset of ovarian cancersTransposon mutagenesis identifies genes that cooperate with mutant Pten in breast cancer progression.Biomarker development, from bench to bedside.Serine protease inhibitor Kazal type 1 promotes epithelial-mesenchymal transition through EGFR signaling pathway in prostate cancer.Is There a Role for Genetic Information in Risk Assessment and Decision Making in Prostate Cancer?Prognostic value of ERG, PTEN, CRISP3 and SPINK1 in predicting biochemical recurrence in prostate cancer.SPINK1 expression is tightly linked to 6q15- and 5q21-deleted ERG-fusion negative prostate cancers but unrelated to PSA recurrence.Identification of genes associated with matrix metalloproteinases in invasive lung adenocarcinoma.
P2860
Q31113966-3C382E22-EDD1-455C-97DA-8AC055B57096Q33796155-1F3477DB-F7FC-40CF-A5FD-9D5F7CEBF68DQ34350077-2AADF479-6D48-468A-8237-B119A91A9822Q35131133-B8898F75-8E4B-4EE0-950D-FF5E1C627924Q35983468-291D8F86-952A-4745-87B2-1164D528505FQ36161911-C0D04E7F-469A-4290-85EA-B3A60DDC809EQ36245402-629CBBCF-4966-4A08-BC70-7D90B3924DDBQ36245896-39651D14-9070-4F06-93E6-2A3C4694A524Q36546449-F8BF4294-7609-4458-ACEA-B1875239A87DQ37473990-A246055F-5264-43A9-810E-599509CC12B6Q38569348-441CC7F3-7F4A-4626-B321-A81E9BE2FDEEQ39016331-7F77BCE2-59B6-4C29-96FD-F99A50FCC267Q39117370-79875F4F-FE96-4317-A343-AF2F6816A669Q42748239-C7E3D23F-E083-447C-BC70-F00E294A54C1Q48030483-786DB8A7-E302-4C3B-95AF-77A77DD1EF78Q55508016-DAA3AE66-BFCA-443A-B40F-E30AB181CCA1
P2860
Combined genomic and phenotype screening reveals secretory factor SPINK1 as an invasion and survival factor associated with patient prognosis in breast cancer
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Combined genomic and phenotype ...... ent prognosis in breast cancer
@ast
Combined genomic and phenotype ...... ent prognosis in breast cancer
@en
type
label
Combined genomic and phenotype ...... ent prognosis in breast cancer
@ast
Combined genomic and phenotype ...... ent prognosis in breast cancer
@en
prefLabel
Combined genomic and phenotype ...... ent prognosis in breast cancer
@ast
Combined genomic and phenotype ...... ent prognosis in breast cancer
@en
P2093
P2860
P356
P1476
Combined genomic and phenotype ...... ent prognosis in breast cancer
@en
P2093
Brendan Pang
Chee Wee Ong
Cyril Dalmasso
Edison T Liu
Kartiki V Desai
Lance David Miller
Manuel Salto-Tellez
Michael A Black
Wendy Weijia Soon
Xiu Bin Chan
P2860
P304
P356
10.1002/EMMM.201100150
P577
2011-06-08T00:00:00Z